In vitro and in vivo antimicrobial potential of lithium complex against multi-drug resistant Acinetobacter baumannii

Microbiol Spectr. 2023 Dec 12;11(6):e0193023. doi: 10.1128/spectrum.01930-23. Epub 2023 Oct 20.

Abstract

Multi-drug resistance (MDR) by virtue of evolving resistance and virulence mechanisms among A. baumannii is a global concern which is responsible for lethal hospital-acquired infections. Therefore, it is crucial to develop new therapeutics against it. Metal complexes are compact structures with diverse mechanisms that the pathogens cannot evade easily which make them a strong drug candidate. In this study, we assessed the in vitro and in vivo efficacy of lithium complex {[Li(phen)2 sal]} against biofilm-forming MDR A. baumannii. The lithium complex displayed strong antimicrobial activity and reduced the pre-formed mature biofilm which is key barrier for antimicrobial action. Moreover, it employs oxidative stress as one of its mode of actions and causes cellular rupturing. Lithium complex was non-toxic and was significantly effective to overcome pneumonia in mice model. These results highlight the untapped potential of metal complexes that can be explored and utilized for combating notorious A. baumannii infections.

Keywords: Acinetobacter baumannii; biofilm; lithium complex; metal complexes; multi drug resistant; nosocomial infections.

MeSH terms

  • Acinetobacter Infections* / drug therapy
  • Acinetobacter baumannii*
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents* / pharmacology
  • Biofilms
  • Coordination Complexes* / pharmacology
  • Drug Resistance, Multiple, Bacterial
  • Lithium / pharmacology
  • Mice
  • Microbial Sensitivity Tests

Substances

  • Anti-Bacterial Agents
  • Lithium
  • Coordination Complexes
  • Anti-Infective Agents